DNA Print Genomics (DNA Print Genomics) Change In Payables And Accrued Expense : $0.96 Mil (TTM As of Sep. 2007)

View and export this data going back to . Start your Free Trial

What is DNA Print Genomics Change In Payables And Accrued Expense?

DNA Print Genomics's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2007 was $-0.16 Mil. It means DNA Print Genomics's Accounts Payable & Accrued Expense declined by $0.16 Mil from Jun. 2007 to Sep. 2007 .

DNA Print Genomics's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2006 was $2.04 Mil. It means DNA Print Genomics's Accounts Payable & Accrued Expense increased by $2.04 Mil from Dec. 2005 to Dec. 2006 .

DNA Print Genomics Change In Payables And Accrued Expense Historical Data

The historical data trend for DNA Print Genomics's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DNA Print Genomics Change In Payables And Accrued Expense Chart

DNA Print Genomics Annual Data

Trend

Dec01

Dec02

Dec03

Dec04

Dec05

Dec06

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

0.42

-0.97

0.78

2.04

DNA Print Genomics Quarterly Data
	Dec02	Mar03	Jun03	Sep03	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															1.55	0.97	0.16	-0.02	-0.16

DNA Print Genomics Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2007 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.96 Mil.

DNA Print Genomics Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of DNA Print Genomics's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

DNA Print Genomics (DNA Print Genomics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DNA Print Genomics Inc (GREY:DNAG) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

1621 West University Parkway, Sarasota, FL, USA, 34243

Website

http://www.dnaprint.com

DNA Print Genomics Inc is a pharmaceutical company that focuses on the human genome sciences. Through its subsidiaries, it is into research and development of genomic products and provides scientific services and tests to the genealogy, forensic, pharmaceutical, and genetics markets; and focuses on personalized medicine; and other operations.

DNA Print Genomics (DNA Print Genomics) Headlines

No Headlines